Joris Galland
1PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (1)
Sort by Publication Date:
|May 24, 2022
Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study.Maël Heiblig, Marcela A Ferrada, Matthew J Koster
Pageof 1
